That is all good and yes NWBO mgmt has overcome huge obstacles to get to this point thanks to their persistence, intelligent use of an extended timeline and ability to fund their minimalist operational level, all good. I think we will find out if the platform is to expand rapidly there is much help needed on most pharma functions as I have mentioned some time ago, including regulatory, clinical, medical, all commercial ones and technical ops. BP's have scale and global reach, both necessary. All good, we will see how they go post GBM launch, hopefully on a rapid development track.
GLTA , much happening here
Bullish